Brief: Surmodics Announces Transcend Trial 24-Month Data To Be Presented At Viva 2022
Oct 26 (Reuters) - Surmodics Inc SRDX.O :
* SURMODICS ANNOUNCES TRANSCEND TRIAL 24-MONTH DATA TO BE
PRESENTED AT VIVA 2022
Source text for Eikon: ID:nBw1TjQYNa
Further company coverage: SRDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SurModics
See all newsU.S. STOCKS ON THE MOVE-Surmodics, Cheniere Energy, American Public Education
U.S. STOCKS ON THE MOVE-Surmodics, Energy stocks, American Public Education
Surmodics jumps after US judge rejects FTC's bid to block acquisition by GTCR
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions